# Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

> **NCT00837707** · PHASE4 · UNKNOWN · sponsor: **Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan** · enrollment: 25 (estimated)

## Conditions studied

- Dyskinesia, Drug-Induced

## Interventions

- **DRUG:** aripiprazole

## Key facts

- **NCT ID:** NCT00837707
- **Lead sponsor:** Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** 2009-08
- **Final completion:** 2010-02
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2009-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00837707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00837707, "Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00837707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*